￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Detailed description of which diseases and indications Cabergoline is suitable for

2026-02-01 22:25:32

Check Details
Precautions and daily monitoring requirements for taking momelotinib

2026-02-01 22:25:32

Check Details
How long does it take to safely stop taking Bikeren Prenol Tablets (Bituvi) and reference for the medication cycle?

2026-02-01 22:25:32

Check Details
Summary of clinical efficacy and patient use feedback of decavatinib

2026-02-01 22:25:32

Check Details
Analysis of the mechanism and principle of action of Apremilast (Otelor) in the treatment of psoriasis

2026-02-01 22:25:32

Check Details
What blood, liver and kidney indicators need to be checked regularly while using Valganciclovir?

2026-02-01 22:25:32

Check Details
Is osimertinib (Tagrisso) suitable for the treatment of lung squamous cell carcinoma and analysis of its efficacy

2026-02-01 22:25:32

Check Details
Can I eat immediately after taking Eltrombopag (Revlan) and what are my dietary recommendations?

2026-02-01 22:25:32

Check Details
Possible side effects and treatment methods during taking Roprostim (Huierning)

2026-02-01 22:25:32

Check Details
What to do if Midostaurin can cause an allergic skin reaction

2026-02-01 22:25:32

Check Details
Does long-term use of cabergoline cause excessive gastric acid secretion?

2026-02-01 22:25:32

Check Details
Which groups are not suitable for taking Momelotinib and tips on potential risks

2026-02-01 22:25:32

Check Details
Category
相关知识